pain; allergy; sore throat; runny nose; blocked nose; itchy eyes; caused my asthma to get worse; lump in my arm; my arm has never recovered and i often feel pain; this is a spontaneous report received from a contactable reporter(s) (consumer or other non hcp) from the regulatory agency (ra). the reporter is the patient. regulatory number: gb-mhra-webcovid-202202272030465950-c2jep (ra). other case identifier(s): gb-mhra-adr 26657270 (ra). a female patient received bnt162b2 (comirnaty) (batch/lot number: unknown) as dose 2, single for covid-19 immunisation. relevant medical history included: "asthma" (unspecified if ongoing). the patient's concomitant medications were not reported. vaccination history included: covid-19 vaccine (dose 1; manufacturer unknown), for covid-19 immunisation. the patient was young fit and healthy. the patient had no symptoms associated with covid-19 and was not enrolled in the clinical trial. the following information was reported: pain (disability), outcome "recovered", described as "pain"; hypersensitivity (disability), outcome "not recovered", described as "allergy"; the patient since having her vaccines, she developed allergies to everything, she woke up every morning with oropharyngeal pain (disability), outcome "unknown", described as "sore throat", rhinorrhoea (disability), outcome "unknown", described as "runny nose", nasal obstruction (disability), outcome "unknown", described as "blocked nose", eye pruritus (disability), outcome "unknown", described as "itchy eyes"; it caused her asthma (disability), outcome "unknown", described as "asthma to get worse", she had to use an inhaler daily and she always developed limb mass (disability), outcome "not recovered", described as "lump in arm" on her second dose, which affected the use of her arm, she further stated that pain in extremity (disability), outcome "not recovered", described as "arm has never recovered and she often feel pain". the patient underwent the following laboratory tests and procedures: sars-cov-2 test: no - negative covid-19 test. therapeutic measures were taken as a result of asthma. no follow-up attempts are possible; information about lot/batch number cannot be obtained. no further information is expected